Mesoblast
MESO
42 hedge funds and large institutions have $7.89M invested in Mesoblast in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
188% more call options, than puts
Call options by funds: $1.91M | Put options by funds: $663K
24% more capital invested
Capital invested by funds: $6.35M → $7.89M (+$1.54M)
14% more funds holding
Funds holding: 37 → 42 (+5)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
0.08% less ownership
Funds ownership: 0.26% → 0.18% (-0.08%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$430K |
| 2 |
Millennium Management
New York
|
+$369K |
| 3 |
Jane Street
New York
|
+$197K |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$156K |
| 5 |
Goldman Sachs
New York
|
+$114K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.59M |
| 2 |
MGIM
M&G Investment Management
London,
United Kingdom
|
-$1.1M |
| 3 |
HWAM
Hennion & Walsh Asset Management
Parsippany,
New Jersey
|
-$547K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$227K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$152K |
MESO Hedge Fund Activity: Q4 2022 in Review
42 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q4 2022, worth a combined $7.89M — up 24% from $6.35M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MESO positions and 3 closed out — a net gain of 8 holders — while 9 added to existing stakes and 9 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $430K. The largest seller was BlackRock, cutting an estimated $2.59M.
- 42 institutional investors held Mesoblast (MESO) as of Q4 2022, up from 37 in Q3 2022.
- Funds reported $7.89M of Mesoblast stock for Q4 2022, up 24% quarter-over-quarter.
- 11 funds opened new Mesoblast positions in Q4 2022 and 3 closed out, a net change of +8 holders.
- The largest Mesoblast buyer in Q4 2022 was Citadel Advisors, an estimated $430K added.
- The largest Mesoblast seller in Q4 2022 was BlackRock, an estimated $2.59M sold.
Based on aggregated 13F filings for Q4 2022.